image credit: aptar

FDA approves Aptar’s acute repetitive seizures treatment device

December 10, 2019

The US Food and Drug Administration (FDA) has approved Aptar Group’s Unidose Liquid System to treat acute repetitive seizures in those with epilepsy.

Claimed to be the first and only nasal rescue treatment for seizures, Aptar’s Unidose Liquid System is a single-use, ready-to-use one-step nasal delivery device that can deliver a formulation in an emergency.

Non-healthcare professionals can administer the nasal delivery device to a patient during or after a seizure.